SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-058072
Filing Date
2024-03-04
Accepted
2024-03-04 17:37:27
Documents
3
Group Members
DGP CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d799381dsc13da.htm SC 13D/A 45352
2 EX-99.1 d799381dex991.htm EX-99.1 14920
3 EX-99.2 d799381dex992.htm EX-99.2 12096
  Complete submission text file 0001193125-24-058072.txt   74027
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Subject) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90023 | Film No.: 24716525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3000 WESTERN AVENUE SUITE 400 SEATTLE WA 98121
Business Address 3000 WESTERN AVENUE SUITE 400 SEATTLE WA 98121 425-220-2542
CBI USA, Inc. (Filed by) CIK: 0001930189 (see all company filings)

IRS No.: 863703094 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A